AJCP / Meeting AbstrActs pink-tan tissue pieces. The mucosa was tan-pink and congested with a 2.0 × 2.0 × 0.2-cm area of irregular thickening. The wall thickness measured up to 0.3 cm. Microscopic examination revealed exuberant tubulopapillary growth with low-to high-grade dysplasia; focal flat dysplasia; oncocytic, pyloric, and goblet cell metaplasia; marked acute and chronic inflammation; and abscess formation. No invasion of the gallbladder wall or Rokitansky-Aschoff sinuses were identified. The tumor cells were immunoreactive for CK20 (strong) and patchy positive for CK7, MUC1, and MUC5 AC. Tumor cells were negative for MUC2, MUC6, CDX2, and Hep-par. Based on these findings, a diagnosis of intracholecystic papillary-tubular neoplasm, pancreaticobiliary type, with high-grade dysplasia and clear margins was made (T1 lesion). Langerhans cell histiocytosis (LCH) rarely involves liver without systemic manifestation, especially in an adult population. We describe a case of LCH with solitary hepatic involvement that was initially diagnosed as antimitochondrial antibody (AMA)-negative primary biliary cholangitis (PBC), requiring transplantation. When disease recurred, the allograft was lost and the patient required a second transplantation. We have reviewed histopathologic material from both native and allograft specimens, including all biopsies and explant hepatectomies, and clinical data accumulated over a 10-year interval.
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Langerhans cell histiocytosis (LCH) rarely involves liver without systemic manifestation, especially in an adult population. We describe a case of LCH with solitary hepatic involvement that was initially diagnosed as antimitochondrial antibody (AMA)-negative primary biliary cholangitis (PBC), requiring transplantation. When disease recurred, the allograft was lost and the patient required a second transplantation. We have reviewed histopathologic material from both native and allograft specimens, including all biopsies and explant hepatectomies, and clinical data accumulated over a 10-year interval.
A 46-year-old woman with a clinical history of panhypopituitarism presented with jaundice and pruritus. An initial hepatology workup including liver biopsy led to diagnosis of AMA-negative PBC with advanced fibrosis. Within a year, the patient progressed to decompensated cirrhosis requiring transplantation. Her posttransplantation course was complicated by frequent bouts of markedly elevated alkaline phosphatase (>1,000 mg/dL) and gamma-glutamyl transferase with transaminases elevated above 100 mg/dL. These abnormalities, together with the liver biopsy findings of bile duct injury and portal eosinophilic infiltrate, were thought to be episodes of acute cellular rejection that occurred frequently during the first 2 years after transplantation. Her liver enzymes would show some improvement without complete normalization on highdose steroid therapy and become elevated once the therapy stopped. Three years after transplantation, the diagnosis of LCH was established, and 4 years later, the patient lost the liver graft. The explanted allograft revealed patchy distribution of disease, confirming difficulty of LCH diagnosis on a core biopsy. A gold standard for LCH diagnosis relies on morphological and immunohistochemical examination. Establishing a diagnosis of LCH in the liver without systemic involvement is challenging due to the patchy nature of the disease and nonspecific inflammatory infiltrate with eosinophils that can mimic PBC and acute cellular rejection. Awareness of morphological features is crucial for pathologists to render the diagnosis when liver presents as solitary involvement.
Role of Immunohistochemistry in the Classification of Glioblastoma and Anaplastic Astrocytoma in Kenyatta National Hospital
Evelynn Chege, MBChB; University of Nairobi Objectives: To describe the role of immunohistochemistry in the classification of glioblastoma and anaplastic astrocytoma at Kenyatta National Hospital. Methods: Laboratory-based retrospective descriptive study conducted at KNH/UON. Study included diagnosed glioblastoma and anaplastic astrocytoma cases (46). Patients' data and histopathological reports were retrieved from the archives and reanalyzed to identify those with a glioblastoma and anaplastic astrocytoma. Histopathology evaluation was done using formalin-fixed, paraffin-embedded blocks and routine H&E and Ki-67, a cell proliferative marker. Immunohistochemical markers isocitrate dehydrogenase (IDH1) and ATRX were done on tissue microarray blocks. The data were processed in STATA. Descriptive analysis and bivariate analyses were performed to correlate ATRX expression with IDH-1 in the cases. The results were presented in the form of charts, tables, and figures. Results: The lesions were multisited but most commonly in the cerebral cortex. On review of the previous vs current diagnosis: previous WHO grades III and IV (GBM 89.1%, AA 6.5%, AT/RT 2.2%, oligoastrocytoma 2.2%) and current diagnosis after consensus (GBM 95.6%, AA 2.2%, and one case of no tumor). There were 44 GBM cases: classical subtype (77.3%) and one case of oligodencytric (2.3%). Forty-five cases underwent IHC. In the majority of the cases (28/44), Ki-67 had a mitotic score (mean [SD] 27.1% [15.1%]) of the GBM cases. The AA case mitotic rate was 7%. IDH1 mutations were present in 11 of 44 GBM cases and in the AA case. ATRX loss was in 17 of 44
